HML-2 Env has been shown to promote the proliferation of breast cancer and pancreatic cancer cells in vitro and in mouse xenograft models (94, 95), while Np9 was observed to support the growth of leukaemia and teratocarcinoma cells (78, 96). The gene discussed is CLEC10A; the disease is leukemia.